Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 219,467Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Accord healthcare

02 2Amneal Pharmaceuticals

03 2Aurobindo Pharma Limited

04 2Baxter Healthcare Corporation

05 4Farbe Firma

06 6GSK

07 2Hainan Poly Pharm

08 2Hainan Shuangcheng Pharmaceuticals

09 2Hybio Pharmaceutical

10 2JUNO PHARMACEUTICALS CORP.

11 2Jodas Expoim Pvt. Ltd

12 2MSD Pharmaceuticals

13 2Meitheal Pharmaceuticals

14 2Merck & Co

15 2Rising Pharmaceuticals Inc

16 2Sagent Pharmaceuticals

17 2Slate Run Pharmaceuticals

18 1Stanex Drugs and Chemicals

19 2Teva Pharmaceutical Industries

20 3USV Private Limited

21 4Viatris

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML

Packaging :

Approval Date : 2017-11-06

Application Number : 205557

Regulatory Info : DISCN

Registration Country : USA

blank

02

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 75MG/100ML

Packaging :

Approval Date : 2017-11-06

Application Number : 205557

Regulatory Info : DISCN

Registration Country : USA

blank

03

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML

Packaging :

Approval Date : 2016-12-08

Application Number : 205581

Regulatory Info : DISCN

Registration Country : USA

blank

04

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 75MG/100ML

Packaging :

Approval Date : 2016-12-08

Application Number : 205581

Regulatory Info : DISCN

Registration Country : USA

blank

05

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML

Packaging :

Approval Date : 2015-12-08

Application Number : 206127

Regulatory Info : RX

Registration Country : USA

blank

06

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 75MG/100ML

Packaging :

Approval Date : 2015-12-08

Application Number : 206127

Regulatory Info : RX

Registration Country : USA

blank

07

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML

Packaging :

Approval Date : 2020-03-20

Application Number : 207864

Regulatory Info : DISCN

Registration Country : USA

blank

08

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : INTEGRILIN

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1998-05-18

Application Number : 20718

Regulatory Info : DISCN

Registration Country : USA

blank

09

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : INTEGRILIN

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 75MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1998-05-18

Application Number : 20718

Regulatory Info : DISCN

Registration Country : USA

blank

10

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML

Packaging :

Approval Date : 2017-04-18

Application Number : 204589

Regulatory Info : DISCN

Registration Country : USA

blank

11

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 75MG/100ML

Packaging :

Approval Date : 2017-04-18

Application Number : 204589

Regulatory Info : DISCN

Registration Country : USA

blank

12

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML

Packaging :

Approval Date : 2018-03-07

Application Number : 204693

Regulatory Info : RX

Registration Country : USA

blank

13

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 75MG/100ML

Packaging :

Approval Date : 2018-03-07

Application Number : 204693

Regulatory Info : RX

Registration Country : USA

blank

14

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML

Packaging :

Approval Date : 2015-06-12

Application Number : 90854

Regulatory Info : RX

Registration Country : USA

blank

15

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 75MG/100ML

Packaging :

Approval Date : 2015-06-05

Application Number : 91555

Regulatory Info : DISCN

Registration Country : USA

blank

16

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML

Packaging :

Approval Date : 2019-03-14

Application Number : 204361

Regulatory Info : DISCN

Registration Country : USA

blank

17

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 75MG/100ML

Packaging :

Approval Date : 2019-03-14

Application Number : 204361

Regulatory Info : DISCN

Registration Country : USA

blank

18

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML

Packaging :

Approval Date : 2019-03-11

Application Number : 204362

Regulatory Info : DISCN

Registration Country : USA

blank

19

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML

Packaging :

Approval Date : 2018-07-20

Application Number : 203258

Regulatory Info : RX

Registration Country : USA

blank

20

APGA Annual Conference
Not Confirmed
arrow
arrow
APGA Annual Conference
Not Confirmed

EPTIFIBATIDE

Brand Name : EPTIFIBATIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 75MG/100ML

Packaging :

Approval Date : 2018-07-20

Application Number : 203258

Regulatory Info : RX

Registration Country : USA

blank